Programme Biovision Eng Pour Impression A5201010
Total Page:16
File Type:pdf, Size:1020Kb
BIOVISION 2011 - PROGRAM March 27-29 Cité Centre de Congrès, Lyon, France Version: October 20 2010 In partnership with: 2 Table of contents TABLE OF CONTENTS.....................................................................................................3 BIOVISION PARTNERS ....................................................................................................6 PROGRAM FORMAT ........................................................................................................7 PRELIMINARY PROGRAM...............................................................................................9 Decision makers’ perspectives ..................................................................... 9 Plenary 1: Health, a right for all human beings, at any price? ....................................................................... 10 Plenary 2: Drugs and developing countries................................................................................................... 11 Plenary 3: Synthetic biology: reconstructing life? .......................................................................................... 12 Plenary 4: How will we be fed in 2020? ......................................................................................................... 13 Plenary 5: Would Pasteur and Fleming have survived the precautionary principle? .................................... 14 Scientific Advances .................................................................................... 17 Health......................................................................................................... 17 Theme 1: Brain, emotions and social behavior.............................................................................................. 18 Theme 2: Can we “cure” aging? .................................................................................................................... 19 Theme 3: From systems biology to personalized medicine........................................................................... 20 Theme 4: Comprehending human brain function in the future ...................................................................... 21 Theme 5: Cancer research for personalized patient treatment ..................................................................... 22 Theme 6: How to deal with emerging and re-emerging infectious diseases? ............................................... 23 Theme 7: Cell therapy: scientific, therapeutic and ethical challenges........................................................... 24 Environment ............................................................................................... 25 Theme 8: Environment and CO2 ................................................................................................................... 26 Theme 9: Biofuels from Biomass................................................................................................................... 27 Theme 10: Turn Green into Gold................................................................................................................... 28 Nutrition...................................................................................................... 29 Theme 11: Health, nutrition and bacteria....................................................................................................... 30 Theme 12: More food and better food ........................................................................................................... 31 Business in science .................................................................................... 33 Workshop 1: How to address the volume challenge of chronic diseases in emerging countries.................. 34 Workshop 2: How technology will help implementing innovative healthcare delivery? ................................. 35 Workshop 3: How to solve R&D’s challenge with Open Innovation? ............................................................ 36 Workshop 4: New Geography of R&D innovation in infectious and neglected diseases .............................. 37 Social Events.............................................................................................. 39 Gala Dinner.................................................................................................................................................... 39 Welcoming Night............................................................................................................................................ 39 Innovation Dinner........................................................................................................................................... 39 Networking Night............................................................................................................................................ 39 BioVision Award............................................................................................................................................. 39 3 Governance and Organisation ⇒ Steering Committee The Steering Committee approves strategic orientations and gives formal expression to links with some of BioVision’s main partners. Members: • Patrick Aebischer, Chairman, EPFL – Ecole Polytechnique Fédérale de Lausanne (Switzerland) • Gérard Collomb, Senator and Mayor of Lyon, President of the Greater Lyon • Philippe Desmarescaux, Chairman and founder of BioVision • Amir Dossal, Executive Director of UNOP – UN Office for Partnerships (USA) • Eric Froment, Chairman, Fondation Scientifique de Lyon et du Sud-Est • Michel Lussault, Chairman of University of Lyon • Michel Mercier, Minister for Rural Areas and Regional Planning, and Chairman of the Rhone Department General Council • Alain Mérieux, Chairman, Institut Mérieux • Koji Omi, Founder and Chairman of the Science and Technology in Society (STS) forum (Japan) • Jacob Palis, Chairman, TWAS (The Academy of Sciences for the Developing World), (Brazil) • Jean-Jack Queyranne, former minister and Chairman of the Rhone-Alps Region • Ismail Serageldin, Director, Bibliotheca Alexandrina, Founder of BioVisionAlexandria (Egypt) • André Syrota, Chairman, National Life Sciences and Health Alliance • Elias Zerhouni, former director of NIH, Senior fellow, Bill and Melinda Gates Foundation (USA) 4 ⇒ Scientific Committee A new international scientific committee has been established in close partnership with the Academy of Sciences. The Committee is in charge of selecting the programme themes and suggesting speakers. The Committee is responsible for the programme scientific quality and is made up of internationally recognised personalities. Chairman: • Pr. François Gros, Permanent Honorary Secretary of the Academy of Sciences Members: • Pr. Pascale Cossart, Research Director, Institut Pasteur, Academy of Sciences • Pr. Evelyn Fox Keller, Professor, MIT (USA) • Pr. Richard Frackowiak, Professor, University of Lausanne (Switzerland) • Pr. Liselotte Højgaard, Professor, University of Copenhagen (Denmark) • Pr. Gnissa Konate, Director, Institut de l’environnement et des recherches agricoles (Burkina Faso) • Pr. Philippe Kourilsky, Professor, Collège de France • Pr. Jean-Marie Lehn, Professor, Collège de France, Nobel Laureate in Chemistry • Pr. Pierre-Marie Lledo, Director of Research, Institut Pasteur • Pr. Helga Nowotny, President, European Research Council (Austria) • Pr. Michael Oborne, Director of International Futures programme, OCDE (USA) • Pr. Thierry Philip, former Director of the Léon Bérard Centre • Pr. Jacques Samarut, President, ENS-Lyon • Pr. Philippe Sansonetti, Professor, Collège de France • Pr. François Taddei, Research Director, INSERM • Pr. Didier Trono, Dean of the Faculty of Life Sciences, EPFL (Switzerland) 5 BioVision Partners 6 Program Format Official language: English 3 Tracks Scientific Decision makers’ Business in Advances perspectives science · 12 themes: · 6 themes · 3 themes -7 Health - Health -3 Environment - Environment -2 Nutrition - Nutrition ⇓⇓⇓ ⇓⇓⇓ ⇓⇓⇓ 36 sessions 6 plenary sessions 3 round tables 12 round tables ⇓⇓⇓ ⇓⇓⇓ ⇓⇓⇓ 100 speakers 30 speakers 20 speakers 150 speakers 2000 / 2500 participants Preliminary Program Decision makers’ perspectives Please note that all the speakers mentioned in this document have been suggested by the Scientific Committee. Not all of them have been contacted yet. Speakers indicated in bold have accepted our invitation. Subjects and titles of sessions and talks are not final. Plenary 1: Health, a right for all human beings, at any price? Co-organized with Universcience Sunday 27 March 2011 – 13:00 to 14:30 Moderator: Pr. Helga Nowotny (President, European Research Council – ERC) Introduction: Pr. Claudie Haigneré (President, Universcience) - Pr. Zhu Chen (Health Minister, China) - Pr. Michael Marmot (Director, International Institute for Society and Health – University College London; Chairman, Commission on Social Determinants of Health – WHO, UK) - Pr. Michel Kazatchkine (Executive Director, the Global Fund to Fight AIDS, Tuberculosis and Malaria) - Pr. Esther Duflo (Clark Medal Laureate 2010, MIT, USA) - Mr Chris Viehbacher (CEO, Sanofi-aventis) 10 Plenary 2: Drugs and developing countries Sunday 27 March 2011 – 18:00 to 19:30 Moderator: Dr. Elias Zerhouni (Former Director NIH, Chair of Scientific Committee, Foundation Bill & Melinda Gates) - Mr. Hatem el Gabaly (Health Minister, Egypt) - Mr. José Angel Cordova Villalobos (Health Minister, Mexico) - Pr. Awa Marie Coll Seck (Executive Director, Roll Back Malaria, Switzerland)